Vol 18, No 1 (2017)

Table of Contents

Methods

A general model for the estimation of societal costs of lost production and informal care in Italy
Lorenzo Pradelli, Gianni Ghetti
HTML PDF

Original research

The cost of a combination Anti-Retroviral Therapy (cART) optimization pathway as maintenance therapy in HIV-1 infected patients
Roberto Ravasio, Fabio Rigo, Emanuela Lattuada, Ercole Concia, Massimiliano Lanzafame
HTML PDF
Evaluation of the cost saving potential of introducing Benepali® and Flixabi® on the European and Italian markets
Cristina Negrini, Emi Psachoulia
HTML PDF
A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the Italian context
Lorenzo Pradelli, Giovanni Di Perri, Giuliano Rizzardini, Elisa Martelli, Stefano Giardina, Massimiliano Povero
HTML PDF
Economic implications in inflammatory bowel disease: results from a retrospective analysis in an Italian Centre
Angela Variola, Arianna Massella, Andrea Geccherle, Paolo Bocus, Roberto Tessari, Teresa Zuppini, Roberto Ravasio
HTML PDF
Cost-effectiveness analysis of empagliflozin in the treatment of patients with type 2 diabetes and established cardiovascular disease in Italy, based on the results of the EMPA-REG OUTCOME study
Sergio Iannazzo, Edoardo Mannucci, Odette Reifsnider, Aldo Pietro Maggioni
HTML PDF
Budget impact analysis of dabigatran compared with rivaroxaban in the prevention of the thromboembolic risk in patients with non-valvular atrial fibrillation
Maria Grazia Celeste, Francesca De Marco, Claudio Fresco, Giuseppe Musumeci, Roberto Ravasio
HTML PDF
Varenicline treatment for smoking cessation in high risk patients: a budget impact analysis
Federico Spandonaro, Letizia Mancusi, Barbara Polistena
HTML PDF
Budget Impact analysis of the first-line treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) adult patients
Francesco Mennini, Andrea Marcellusi, Raffaella Viti, Giuseppe Saglio
HTML PDF
Equilibrium between resources and expenditure of health sector of Social Security Fund: a case study of Iran
Azadeh Ahmadi Dashtian, Mohsen Mardali
HTML PDF

Letter to the Editor

Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy
Daniela Paola Roggeri, Ezio Zanon, Alessandro Roggeri
HTML PDF
[Use of Kovaltry® in patients with Hemophilia A: clinical and economical aspects from the pivotal clinical trials]
Lucia Sara D'Angiolella, Angelo Claudio Molinari, Paolo Angelo Cortesi, Antonio Coppola, Lorenzo Giovanni Mantovani
HTML PDF
[In reference to "Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]
Matteo Ferrario, Giovanni Giuliani
HTML PDF
[Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]
Lorenzo Pradelli, Paolo Ascierto
HTML PDF

Editorial

Utilization patterns of complementary and alternative medicine in Australia, Canada and the United States: popularity of dietary supplements, mind-body and manipulative therapies
Marina Luketina Sunjka, Ana Pejcic, Mihajlo Jakovljevic
HTML PDF

Acknowledgement to reviewers

Acknowledgement to reviewers (January - December 2017)
 
PDF